Article Versions Notes

Neuzil J, Rohlena J, Werner L, Bielcikova Z. MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126. Cancers. 2023; 15(18):4476. https://doi.org/10.3390/cancers15184476

Neuzil, Jiri, Jakub Rohlena, Lukas Werner, and Zuzana Bielcikova. 2023. "MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126" Cancers 15, no. 18: 4476. https://doi.org/10.3390/cancers15184476

Neuzil, J., Rohlena, J., Werner, L., & Bielcikova, Z. (2023). MitoTam-01 Trial: Mitochondrial Targeting as Plausible Approach to Cancer Therapy. Comment on Yap et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat. Med. 2023, 29, 115–126. Cancers, 15(18), 4476. https://doi.org/10.3390/cancers15184476